Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...

Lazard Asset Management LLC decreased its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...

GMED US After Hours Last Updated: May 23, 2025 7:44 p.m. EDT Delayed quote $ 59.20 0.24 0.41% After Hours Volume: 19.22K Close Chg Chg % $58.96 0.36 0.61% Toggle Chart Options Advanced Charting ...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...

NEW YORK, May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors are advised ...

Results Ten case–control, but no prospective studies were identified. Moderate-to-strong evidence indicates gluteus medius (GMed) activity is delayed and of shorter duration during stair negotiation ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a ...

Tower Research Capital LLC TRC trimmed its stake in Nevro Corp. (NYSE:NVRO – Free Report) by 59.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...